<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40354908</PMID><DateRevised><Year>2025</Year><Month>05</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>May</Month><Day>10</Day></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>Evaluating an information theoretic approach for selecting multimodal data fusion methods.</ArticleTitle><Pagination><StartPage>104833</StartPage><MedlinePgn>104833</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2025.104833</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(25)00062-0</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Interest has grown in combining radiology, pathology, genomic, and clinical data to improve the accuracy of diagnostic and prognostic predictions toward precision health. However, most existing works choose their datasets and modeling approaches empirically and in an ad hoc manner. A prior study proposed four partial information decomposition (PID)-based metrics to provide a theoretical understanding of multimodal data interactions: redundancy, uniqueness of each modality, and synergy. However, these metrics have only been evaluated in a limited collection of biomedical data, and the existing work does not elucidate the effect of parameter selection when calculating the PID metrics. In this work, we evaluate PID metrics on a wider range of biomedical data, including clinical, radiology, pathology, and genomic data, and propose potential improvements to the PID metrics.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We apply the PID metrics to seven different modality pairs across four distinct cohorts (datasets). We compare and interpret trends in the resulting PID metrics and downstream model performance in these multimodal cohorts. The downstream tasks being evaluated include predicting the prognosis (either overall survival or recurrence) of patients with non-small cell lung cancer, prostate cancer, and glioblastoma.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We found that, while PID metrics are informative, solely relying on these metrics to decide on a fusion approach does not always yield a machine learning model with optimal performance. Of the seven different modality pairs, three had poor (0%), three had moderate (66%-89%), and only one had perfect (100%) consistency between the PID values and model performance. We propose two improvements to the PID metrics (determining the optimal parameters and uncertainty estimation) and identified areas where PID metrics could be further improved.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The current PID metrics are not accurate enough for estimating the multimodal data interactions and need to be improved before they can serve as a reliable tool. We propose improvements and provide suggestions for future work. Code: https://github.com/zhtyolivia/pid-multimodal.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Tengyue</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Bioengineering, Medical &amp; Imaging Informatics, Department of Radiological Sciences, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, 90024, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Ruiwen</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Bioengineering, Medical &amp; Imaging Informatics, Department of Radiological Sciences, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, 90024, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luong</LastName><ForeName>Kha-Dinh</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Department of Computer Science, University of California, Santa Barbara (UCSB), Santa Barbara, 93117, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Bioengineering, Medical &amp; Imaging Informatics, Department of Radiological Sciences, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, 90024, CA, USA. Electronic address: whsu@mednet.ucla.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Model performance</Keyword><Keyword MajorTopicYN="N">Multimodal data fusion</Keyword><Keyword MajorTopicYN="N">Multimodal interactions</Keyword><Keyword MajorTopicYN="N">Partial information decomposition</Keyword></KeywordList><CoiStatement>Declaration of competing interest William Hsu reports funding support from the National Institutes of Health, Agency for Healthcare Research and Quality, Early Diagnostics Inc, personal fees from the Radiological Society of North America related to editorial board work, and consulting fees from LungLife AI, Inc. The other au- thors do not report any conflicts.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>13</Day><Hour>0</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>13</Day><Hour>0</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>12</Day><Hour>19</Hour><Minute>31</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40354908</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2025.104833</ArticleId><ArticleId IdType="pii">S1532-0464(25)00062-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>